tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Kevin Degeeter, 106 are a BUY (92.17%), 8 are a HOLD (6.96%), 1 are a SELL (0.87%).
Analyst Kevin Degeeter, currently employed at LADENBURG, carries an average stock price target met ratio of 53.28% that have a potential upside of 52.14% achieved within 313 days. Previously, Kevin Degeeter worked at OPPENHEIMER.
Kevin Degeeter’s has documented 212 price targets and ratings displayed on 33 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on NVCR, Novocure Ltd at 08-Jul-2025.
Analyst best performing recommendations are on CBIO (CATALYST BIOSCIENCES).
The best stock recommendation documented was for NVTA (INVITAE CORP) at 1/12/2021. The price target of $51 was fulfilled within 1 day with a profit of $3.41 (7.17%) receiving and performance score of 71.65.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 09-Apr-2025
$7
$5.88 (525.00%)
$11
3 months 14 days ago
(24-Nov-2025)
0/3 (0%)
$5.32 (316.67%)
Buy Since 20-May-2025
9 months 18 days ago
(20-May-2025)
1/1 (100%)
$2520 (42.86%)
25
Hold Since 28-Aug-2024
$4
$2.88 (257.14%)
$60
11 months 8 days ago
(02-Apr-2025)
2/5 (40%)
$0.25 (6.67%)
8
Hold Since 10-Sep-2024
1 years 3 months 20 days ago
(18-Nov-2024)
1/3 (33.33%)
$53.4 (80.18%)
69
Buy
$80
3 years 2 months 5 days ago
(05-Jan-2023)
2/3 (66.67%)
$58.3 (268.66%)
204
What Year was the first public recommendation made by Kevin Degeeter?
